Highlander Capital Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-500
Closed -$10K 750
2018
Q1
$10K Sell
500
-11,550
-96% -$209K 0.01% 586
2017
Q4
$220K Hold
12,050
0.16% 156
2017
Q3
$270K Hold
12,050
0.21% 127
2017
Q2
$291K Sell
12,050
-4,050
-25% -$86.1K 0.23% 119
2017
Q1
$308K Hold
16,100
0.25% 111
2016
Q4
$315K Sell
16,100
-6,743
-30% -$122K 0.27% 100
2016
Q3
$361K Buy
22,843
+11,943
+110% +$184K 0.32% 88
2016
Q2
$154K Hold
10,900
0.14% 182
2016
Q1
$183K Buy
10,900
+2,400
+28% +$42.2K 0.17% 149
2015
Q4
$191K Sell
8,500
-2,500
-23% -$51.5K 0.18% 148
2015
Q3
$241K Buy
11,000
+945
+9% +$23.6K 0.23% 123
2015
Q2
$248K Sell
10,055
-450
-4% -$10.1K 0.22% 117
2015
Q1
$215K Hold
10,505
0.19% 135
2014
Q4
$210K Sell
10,505
-8,169
-44% -$140K 0.18% 139
2014
Q3
$275K Sell
18,674
-4,000
-18% -$63.7K 0.26% 101
2014
Q2
$417K Buy
22,674
+1,300
+6% +$21.6K 0.38% 70
2014
Q1
$402K Sell
21,374
-8,000
-27% -$164K 0.38% 70
2013
Q4
$549K Sell
29,374
-5,830
-17% -$84.8K 0.52% 47
2013
Q3
$387K Buy
35,204
+2,700
+8% +$26.6K 0.39% 68
2013
Q2
$309K Buy
+32,504
New +$283K 0.33% 89

Other funds holding ATRC

Highlander Capital Management's ATRC Position: Q2 2018 in Review

Highlander Capital Management sold out of AtriCure (ATRC) in Q2 2018, closing a stake of 500 shares — an estimated $10K sold.

Highlander Capital Management first reported a position in ATRC in Q2 2013 and held it in 20 quarters. The position peaked at $549K in Q4 2013. 108 funds tracked by Wall St. Rank hold ATRC as of Q2 2018.

  • Highlander Capital Management reported no remaining AtriCure position as of Q2 2018 after selling out during the quarter.
  • Highlander Capital Management sold 500 AtriCure shares in Q2 2018, an estimated $10K.
  • Highlander Capital Management first reported a position in AtriCure in Q2 2013 and held it in 20 quarters.
  • Highlander Capital Management's AtriCure position peaked at $549K in Q4 2013.
  • 108 funds tracked by Wall St. Rank held AtriCure as of Q2 2018.

Based on Highlander Capital Management's 13F filing for Q2 2018, filed 15 Aug 2018.